Zobrazeno 1 - 10 of 17 pro vyhledávání: '"Ashley, Saunders"'
1
Defining ruxolitinib failure and transition to next-line therapy for patients with myelofibrosis: a modified Delphi panel consensus study
Autor: John Mascarenhas, Hiep Nguyen, Ashley Saunders, Louisa Oliver, Hannah Tomkinson, Richard Perry, Ali McBride
Publikováno v: Future Oncology.
Aim: To define ruxolitinib failure and develop parameters to guide transition to next-line therapy for patients with myelofibrosis. Methods: A modified Delphi panel with 14 hematologists-oncologists. Survey concepts included defining primary refracto
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f6d9e95df42c6a073948fdf95996fdbb
https://doi.org/10.2217/fon-2022-1298
Zobrazit plný text záznamu
4
Akademický článek
Aryl Hydrocarbon Receptor Nuclear Translocator in Vascular Smooth Muscle Cells Is Required for Optimal Peripheral Perfusion Recovery
Autor: Anna Henry Borton, Bryan L. Benson, Lee E. Neilson, Ashley Saunders, M. Amer Alaiti, Alex Y. Huang, Mukesh K. Jain, Aaron Proweller, Diana L. Ramirez‐Bergeron
Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 11 (2018)
BackgroundLimb ischemia resulting from peripheral vascular disease is a common cause of morbidity. Vessel occlusion limits blood flow, creating a hypoxic environment that damages distal tissue, requiring therapeutic revascularization. Hypoxia‐induc
Externí odkaz: https://doaj.org/article/7466c80857fa4d24ae4aefeff2a4414f
Zobrazit plný text záznamu
5
Cardiac involvement in hydrocarbon inhalant toxicity — role of cardiac magnetic resonance imaging: A case report
Autor: Purvi Parwani, Shevel Dacosta Davis, Lauren Bitterman, George Jolly, Hana Kazbour, Ashley Saunders, Saif Ali
Publikováno v: World Journal of Cardiology
BACKGROUND We report a patient who was diagnosed with toxic myopericarditis secondary to hydrocarbon abuse using cardiac magnetic resonance imaging (CMR). CASE SUMMARY A 25-year-old male presented to emergency department with chest pain for 3 d. Pati
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7b9c72f2a16836575e0432390e81d22
http://europepmc.org/articles/PMC8554358
Zobrazit plný text záznamu
6
MPN-036 Treatment Failure and Transition to Next-Line Therapy in Myelofibrosis: A Modified Delphi Panel Approach
Autor: John Mascarenhas, Hiep Nguyen, Ashley Saunders, Louisa Oliver, Hannah Tomkinson, Richard Perry, Ali McBride
Publikováno v: Clinical lymphoma, myelomaleukemia. 22
Ruxolitinib (RUX) is a first-line treatment for intermediate or high-risk myelofibrosis (MF) and was shown to improve splenomegaly and MF symptoms; however, patients experience loss of response and discontinuation rates are high (40%-70%). New treatm
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a19c8d861dcb1399913e870f5e1d411
https://pubmed.ncbi.nlm.nih.gov/36163980
Zobrazit plný text záznamu
10
Impact of acute toxicities associated with chimeric antigen receptor (CAR) T-cell therapy on health-related quality of life (HRQOL) in relapsed or refractory (R/R) large B-cell lymphoma (LBCL)
Autor: Donald Patrick, Shauna McManus, Lauren Podger, Ashley Saunders, Julia Braverman, Fei Fei Liu, Scott J. Keating
Publikováno v: Journal of Clinical Oncology. 40:294-294
294 Background: TRANSCEND NHL 001 (TRANSCEND; NCT02631044) evaluated efficacy and safety of the CAR T cell therapy lisocabtagene maraleucel (liso-cel) as third-line or later treatment in patients with R/R LBCL. Prior research demonstrated improvement
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::927247990f3c3dda1ed504096dc86129
https://doi.org/10.1200/jco.2022.40.28_suppl.294
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje